4//SEC Filing
Paulsen Gisela 4
Accession 0001493152-22-023387
CIK 0001642380other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 8:22 PM ET
Size
6.6 KB
Accession
0001493152-22-023387
Insider Transaction Report
Form 4
Paulsen Gisela
Former President and COO
Transactions
- Award
Common Stock, no par value
2022-08-15+175,000→ 191,500 total - Award
Common Stock, no par value
2022-08-15+350,000→ 541,500 total
Footnotes (2)
- [F1]The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service from the date of grant until the vesting date.
- [F2]The Restricted Stock Units shall vest on January 1, 2024 based on the achievement of a pre-determined financial objective related to the Issuer's available cash.
Documents
Issuer
Oncocyte Corp
CIK 0001642380
Entity typeother
Related Parties
1- filerCIK 0001807104
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 8:22 PM ET
- Size
- 6.6 KB